Isolation of novel synthetic prion strains by amplification in transgenic mice coexpressing wild-type and anchorless prion proteins

Journal of Virology

Volumn 86, Issue 21, 2012, Pages 11763-11778

  Raymond, Gregory J ^a   Race, Brent ^a   Hollister, Jason R ^a   Offerdahl, Danielle K ^a   Moore, Roger A ^a   Kodali, Ravindra ^a,b   Raymond, Lynne D ^a   Hughson, Andrew G ^a   Rosenke, Rebecca ^a   Long, Dan ^a   Dorward, David W ^a   Baron, Gerald S ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; GLYCOSYLPHOSPHATIDYLINOSITOL; PRION PROTEIN; PROTEINASE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; HISTOPATHOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; SCRAPIE AGENT; TRANSGENIC MOUSE; VIRUS ISOLATION; VIRUS STRAIN; WILD TYPE;

ANIMALS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PRIONS; RECOMBINANT PROTEINS;

ANIMALIA; CRICETINAE; MAMMALIA; MAMMALIAN PRION; MUS; MUS MUSCULUS;

EID: 84869015437     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01353-12     Document Type: Article

References (63)

1. Atarashi R, et al. 2007. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat. Methods 4:645-650.
2. Ayers JI, Kincaid AE, Bartz JC. 2009. Prion strain targeting independent of strain-specific neuronal tropism. J. Virol. 83:81-87.
3. Ayers JI, et al. 2011. The strain-encoded relationship between PrP replication,stability and processing in neurons is predictive of the incubation period of disease. PLoS Pathog. 7:e1001317. doi:10.1371/journal.ppat.1001317.
4. Baron GS, et al. 2011. Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra. Biochemistry 50:4479-4490.
5. Barria MA, Mukherjee A, Gonzalez-Romero D, Morales R, Soto C.2009. De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog. 5:e1000421. doi:10.1371/journal.ppat.1000421.
6. 6. Basler K, et al. 1986. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46:417-428.
7. Bett C, et al. 2012. Biochemical properties of highly neuroinvasive prion strains. PLoS Pathog. 8:e1002522. doi:10.1371/journal.ppat.1002522.
8. Bocharova OV, Breydo L, Parfenov AS, Salnikov VV, Baskakov IV.2005. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc). J. Mol. Biol. 346:645-659.
9. Bocharova OV, et al. 2006. Annealing prion protein amyloid fibrils at high temperature results in extension of a proteinase K-resistant core. J.Biol. Chem. 281:2373-2379.
10. Castilla J, et al. 2008. Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 134:757-768.
11. Castilla J, Saa P, Hetz C, Soto C. 2005. In vitro generation of infectious scrapie prions. Cell 121:195-206.
12. Caughey B, Baron GS, Chesebro B, Jeffrey M. 2009. Getting a grip on prions: oligomers, amyloids, anchors and pathological membrane interactions.Annu. Rev. Biochem. 78:177-204.
13. Chesebro B, et al. 2010. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring. PLoS Pathog. 6:e1000800. doi:10.1371/journal.ppat.1000800.
14. Chesebro B, et al. 1985. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 315:331-333.
15. Chesebro B, et al. 2005. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308:1435-1439.
16. Chianini F, et al. 2012. Rabbits are not resistant to prion infection. Proc.Natl. Acad. Sci. U.S.A. 109:5080-5085.
17. Colby DW, et al. 2009. Design and construction of diverse mammalian prion strains. Proc. Natl. Acad. Sci. U.S.A. 106:20417-20422.
18. Colby DW, et al. 2010. Protease-sensitive synthetic prions. PLoS Pathog.6:e1000736. doi:10.1371/journal.ppat.1000736.
19. Cosseddu GM, et al. 2011. Ultra-efficient PrP(Sc) amplification highlights potentialities and pitfalls of PMCA technology. PLoS Pathog.7:e1002370. doi:10.1371/journal.ppat.1002370.
20. Deleault NR, Harris BT, Rees JR, Supattapone S. 2007. Formation of native prions from minimal components in vitro. Proc. Natl. Acad. Sci.U.S.A. 104:9741-9746.
21. Deleault NR, Kascsak R, Geoghegan JC, Supattapone S. 2010. Speciesdependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry 49:3928-3934.
22. Deleault NR, et al. 2012. Isolation of phosphatidylethanolamine as solitary cofactor for prion formation in the absence of nucleic acids. Proc.Natl. Acad. Sci. U.S.A. 109:E1938-E1946.
23. Fischer M, et al. 1996. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J.15:1255-1264.
24. Geoghegan JC, et al. 2007. Selective incorporation of polyanionic molecules into hamster prions. J. Biol. Chem. 282:36341-36353.
25. Green KM, et al. 2008. Accelerated high fidelity prion amplification within and across prion species barriers. PLoS Pathog. 4:e1000139. doi:10.1371/journal.ppat.1000139.
26. Griffith JS. 1967. Self-replication and scrapie. Nature 215:1043-1044.
27. Imamura M, et al. 2011. Glycosylphosphatidylinositol anchordependent stimulation pathway required for generation of baculovirusderived recombinant scrapie prion protein. J. Virol. 85:2582-2588.
28. Jackson WS, et al. 2009. Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron 63:438-450.
29. Karapetyan YE, et al. 2009. Prion strain discrimination based on rapid in vivo amplification and analysis by the cell panel assay. PLoS One 4:e5730.doi:10.1371/journal.pone.0005730.
30. Kim CL, et al. 2004. Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation. J. Gen. Virol. 85:3473-3482.
31. Kim JI, et al. 2010. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J. Biol.Chem. 285:14083-14087.
32. Klingeborn M, Race B, Meade-White KD, Chesebro B. 2011. Lower specific infectivity of protease-resistant prion protein generated in cellfree reactions. Proc. Natl. Acad. Sci. U.S.A. 108:E1244-E1253.
33. Legname G, et al. 2004. Synthetic mammalian prions. Science 305:673-676.
34. Legname G, et al. 2006. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc. Natl. Acad. Sci.U.S.A. 103:19105-19110.
35. Makarava N, et al. 2010. Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol. 119:177-187.
36. Makarava N, et al. 2011. Genesis of mammalian prions: from noninfectious amyloid fibrils to a transmissible prion disease. PLoS Pathog.7:e1002419. doi:10.1371/journal.ppat.1002419.
37. Makarava N, et al. 2012. A new mechanism for transmissible prion diseases.J. Neurosci. 32:7345-7355.
38. Meyerett C, et al. 2008. In vitro strain adaptation ofCWDprions by serial protein misfolding cyclic amplification. Virology 382:267-276.
39. Miller MB, Geoghegan JC, Supattapone S. 2011. Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.PLoS Pathog. 7:e1002128. doi:10.1371/journal.ppat.1002128.
40. Murayama Y, et al. 2010. Sulfated dextrans enhance in vitro amplification of bovine spongiform encephalopathy PrP(Sc) and enable ultrasensitive detection of bovine PrP(Sc). PLoS One 5:e13152. doi:10.1371/journal.pone.0013152.
41. Oesch B, et al. 1985. A cellular gene encodes scrapie PrP 27-30 protein.Cell 40:735-746.
42. Parchi P, et al. 1998. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Straussler-Scheinker disease. Proc. Natl.Acad.Sci.U.S.A.95:8322-8327.
43. Piccardo P, et al. 2001. Prion proteins with different conformations accumulate in Gerstmann-Straussler-Scheinker disease caused by A117V and F198S mutations. Am. J. Pathol. 158:2201-2207.
44. Piro JR, et al. 2011. Seeding specificity and ultrastructural characteristics of infectious recombinant prions. Biochemistry 50:7111-7116.
45. Prusiner SB. 1982. Novel proteinaceous infectious particles cause scrapie.Science 216:136-144.
46. Prusiner SB, Groth DF, Bolton DC, Kent SB, Hood LE. 1984. Purification and structural studies of a major scrapie prion protein. Cell 38:127-134.
47. Saa P, Castilla J, Soto C. 2006. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J. Biol.Chem. 281:35245-35252.
48. Saborio GP, Permanne B, Soto C. 2001. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411:810-813.
49. Safar J, et al. 1998. Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 4:1157-1165.
50. Shikiya RA, Ayers JI, Schutt CR, Kincaid AE, Bartz JC. 2010. Coinfecting prion strains compete for a limiting cellular resource. J. Virol. 84:5706-5714.
51. Shikiya RA, Bartz JC. 2011. In vitro generation of high-titer prions. J.Virol. 85:13439-13442.
52. Sigurdson CJ, et al. 2009. De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc. Natl. Acad. Sci. U.S.A.106:304-309.
53. Smirnovas V, et al. 2011. Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nat. Struct.Mol. Biol.
54. Soto C. 2011. Prion hypothesis: the end of the controversy? Trends Biochem. Sci. 36:151-158.
55. Soto C, Saborio GP, Anderes L. 2002. Cyclic amplification of protein misfolding: application to prion-related disorders and beyond. Trends Neurosci.25:390-394.
56. Stahl N, Borchelt DR, Hsiao K, Prusiner SB. 1987. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51:229-240.
57. Stöhr J, et al. 2011. Spontaneous generation of anchorless prions in transgenic mice. Proc.Natl.Acad.Sci.U.S.A.108:21223-21228.
58. Tagliavini F, et al. 1994. Amyloid fibrils in Gerstmann-Straussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell 79:695-703.
59. Wadsworth JD, et al. 2001. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358:171-180.
60. Wang F, Wang X, Yuan CG, Ma J. 2010. Generating a prion with bacterially expressed recombinant prion protein. Science 327:1132-1135.
61. Weber P, et al. 2007. Generation of genuine prion infectivity by serial PMCA. Vet. Microbiol. 123:346-357.
62. Williamson RA, et al. 1998. Mapping the prion protein using recombinant antibodies. J. Virol. 72:9413-9418.
63. Zou WQ, et al. 2010. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann. Neurol. 68:162-172.